Vaxart Encourages All Stockholders of Record as of April
SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today encourages its stockholders of record on April 28, 2023,...
Stay updated with breaking news from Nasdaq Vxrt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today encourages its stockholders of record on April 28, 2023,...
SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the pricing of its underwritten public...
Vaxart, Inc. (NASDAQ:VXRT – Get Rating)’s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.02 and traded as low as $0.85. Vaxart shares last traded at $0.86, with a volume of 512,683 shares traded. Vaxart Price Performance The firm has a market […]
Vaxart (NASDAQ:VXRT – Get Rating) and 4D Molecular Therapeutics (NASDAQ:FDMT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings. Risk and Volatility Vaxart has a beta of 0.82, […]
Funding and support provided by Bill & Melinda Gates Foundation Study will focus on determining the ability of oral vaccine tablets to induce breast...